 |
|
|
|
|
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Oricula Therapeutics, LLC
| | | | | Phone: | (206) 322-7526 | | Year Established: | 2013 | | Main Contact: | Malcolm Gleser, MD, PhD, CEO | | | | Company Description | | Oricula Therapeutics is a start-up biotechnology company with a mission to develop medicines that protect hearing and balance from the effects of ototoxic drugs and aging. Oricula's first product will be the first medication to prevent hearing loss in patients undergoing treatment for serious infections with aminoglycoside antibiotics. | |
|
|
|
|
|
|
|
